


\multicolumn{1}{|c|}{ } & \multicolumn{1}{c|}{ } & \multicolumn{1}{c|}{ } & \multicolumn{2}{c|}{Ochalek (2018)} & \multicolumn{2}{c|}{Woods (2016)} & \multicolumn{2}{c|}{P-Rivi√®re (2023)} \\
\cline{4-5} \cline{6-7} \cline{8-9}
Comparison & Number of evaluations & Study decision & High & Low & High & Low & High & Low\\
\hline
PCV7 vs NoVax & 24 & 83\% & 54\% & 50\% & 58\% & 29\% & 62\% & 46\%\\
\hline
PCV10 vs NoVax & 77 & 90\% & 62\% & 48\% & 60\% & 22\% & 70\% & 43\%\\
\hline
PCV13 vs NoVax & 64 & 89\% & 66\% & 59\% & 66\% & 34\% & 69\% & 52\%\\
\hline
PCV13 vs PCV10 & 32 & 78\% & 72\% & 66\% & 72\% & 62\% & 69\% & 62\%\\
\hline
Others & 12 & 92\% & 83\% & 75\% & 83\% & 50\% & 83\% & 75\%\\
\hline
All comparisons & 209 & 87\% & 65\% & 56\% & 65\% & 34\% & 69\% & 51\%\\
\hline

